Metyrapone as a Predictive Tool in Cushing’s Syndrome
Author Information
Author(s): Tsujimoto Yasutaka, Yamamoto Naoki, Bando Hironori, Yamamoto Masaaki, Ohmachi Yuka, Motomura Yuma, Oi-Yo Yuka, Sasaki Yuriko, Suzuki Masaki, Urai Shin, Takahashi Michiko, Iguchi Genzo, Ogawa Wataru, Fukuoka Hidenori
Primary Institution: Kobe University Graduate School of Medicine
Hypothesis
Can metyrapone responsiveness predict optimal dosage and timing for patients with Cushing’s syndrome?
Conclusion
The duration of response to metyrapone is unpredictable and does not correlate with patient characteristics.
Supporting Evidence
- 20% of patients required 4 hours or more to reach nadir after metyrapone administration.
- Fnadir was positively correlated with early-morning serum cortisol levels.
- ΔF was positively correlated with late-night serum cortisol levels.
Takeaway
This study shows that how well metyrapone works can be different for each patient, and we need to track its effects to find the best dose.
Methodology
A single-center retrospective observational study measuring serum cortisol levels in patients after a single dose of metyrapone.
Potential Biases
Selection bias may have occurred as not all patients were included in the study.
Limitations
The study had a small sample size and was conducted at a single center, which may limit the generalizability of the findings.
Participant Demographics
87% women, median age 51.7 years, with 7 having Cushing’s disease and 8 having adrenal Cushing’s syndrome.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website